GIP
CLB icon

Granite Investment Partners’s Core Laboratories CLB Stock Holding History

Granite Investment Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-53,774
Closed -$2.03M – 279
2019
Q4 		$2.03M Sell
53,774
-383,714
-88% -$17.2M 0.1% 193
2019
Q3 		$20.4M Buy
437,488
+171,179
+64% +$7.96M 1.05% 22
2019
Q2 		$13.9M Buy
+266,309
New +$15.6M 0.75% 57
2014
Q2 		– Sell
-1,128
Closed -$224K – 290
2014
Q1 		$224K Hold
1,128
– – 0.03% 245
2013
Q4 		$215K Buy
+1,128
New +$210K 0.03% 251

Other funds holding CLB

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Granite Investment Partners's CLB Position: Q1 2020 in Review

Granite Investment Partners sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 53,774 shares — an estimated $2.03M sold.

Granite Investment Partners first reported a position in CLB in Q4 2013 and held it in 5 quarters. The position peaked at $20.4M in Q3 2019. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Granite Investment Partners reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Granite Investment Partners sold 53,774 Core Laboratories shares in Q1 2020, an estimated $2.03M.
  • Granite Investment Partners first reported a position in Core Laboratories in Q4 2013 and held it in 5 quarters.
  • Granite Investment Partners's Core Laboratories position peaked at $20.4M in Q3 2019.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Granite Investment Partners's 13F filing for Q1 2020, filed 14 May 2020.